Digest Network Come funziona
Network
/
Società
bi
Non verificato

bioAffinity Technologies, Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaOncologiaSaluteScienza

62 comunicati stampa

Guarda tutti i comunicati
03/12/2025
Eventi
Fiere
Industria
Attrezzature medico-sanitarie
Sanità
Biotecnologia
Medicina nucleare
Salute
Oncologia
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
14/11/2025
Scienza
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Salute
Oncologia
Mercato azionario
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Software
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Tecnica
Medicina - Varie
Industria
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
28/10/2025
Tecnica
Scienza
Attrezzature medico-sanitarie
Biotecnologia
Salute
Information Technology
Oncologia
Industria
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
20/10/2025
Scienza
Tecnica
Attrezzature medico-sanitarie
Associazioni/Professionisti
Biotecnologia
Salute
Oncologia
Eventi
Industria
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
16/10/2025
Tecnica
Attrezzature medico-sanitarie
Software
Biotecnologia
Medicina nucleare
Salute
Oncologia
Industria
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
15/10/2025
Biotecnologia
Salute
Tecnica
Oncologia
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
09/10/2025
Biotecnologia
Salute
Oncologia
Finanza
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
08/10/2025
Biotecnologia
Salute
Oncologia
Finanza
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
07/10/2025
Scienza
Sanità
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Salute
Industria
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0